Skip to main content
. 2013 Sep 24;141(3):461–470. doi: 10.1007/s10549-013-2697-5

Fig. 3.

Fig. 3

Analysis of progression-free survival (PFS) by baseline characteristics and treatment patterns in black and white patients. BMI body mass index, CI confidence interval, CNS central nervous system, CVD cardiovascular, ER estrogen receptor, HR hazard ratio, met metastases, PR progesterone receptor